Reserved area

Credentials and contents in the EryDel “RESERVED AREA” are strictly confidential and the access is authorized only for the medical staff operating the EDS in the ATTeST study. The Content of the “RESERVED AREA” should not be copied, distributed or reproduced in whole or in part, nor distributed to any third party if not for the  training purpose of authorized EDS Operators. The Content of the “RESERVED AREA” is only for medically trained staff.

I Agree


Erydel’s technology platform, based upon the encapsulation of drugs or diagnostics into Red Blood Cells, could offer advantages in a wide range of applications and opens to unlimited new therapeutic approaches. Application of erythrocytes as containers for various drugs could minimize toxicity, reduce the risk of side effects and pathologic immune reactions against encapsulated agents as well as improving their efficacy, leading to better patient compliance.

Where We Are